C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2006
12/26/2006	US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006	US7153815 Insecticide containing hydrazone derivative as the active ingredient and novel hydrazone derivative
12/21/2006	WO2006135323A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives
12/21/2006	WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	WO2006134467A1 N-(pyridin-2-yl)-sulfonamide derivatives
12/21/2006	WO2006134224A1 Controlling the regio- and stereospecificity of enzyme catalysis with guide molecules
12/21/2006	WO2006134040A1 Anthranilic acid derivatives
12/21/2006	WO2006133823A1 Benzanilides with insecticidal activity
12/21/2006	WO2006133559A1 Reversible inhibitors of monoamine oxidase a and b
12/21/2006	WO2006089658A3 Nk1 antagonists
12/21/2006	WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases
12/21/2006	WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof
12/21/2006	US20060287527 Process for producing acrylic acid derivative
12/21/2006	US20060287525 For post-chemotherapy or post-operative surgery nausea and vomitting; sustained release
12/21/2006	US20060287396 4-aryl quinols and analogs thereof as therapeutic agents
12/21/2006	US20060287338 Metalloproteinase inhibitor compounds
12/21/2006	US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006	US20060287280 N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; zinc metallopeptidase inhibitors; promoting faster regeneration of bone mass after bone fractures, implantation of orthopedic and dental prostheses; osteogenesis stimulant; control phosphate metabolism
12/21/2006	US20060287250 Intermediates: omega(1-haloalkoxycarbonylamino)alkanoates, e.g., Benzyl 1-{[(1-Chloroethoxy)carbonyl]aminomethyl}-1-Cyclohexane Acetate
12/21/2006	DE19843489B4 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung Benzoylguanidine-derivatives having advantageous properties, to processes for their preparation and their use in the manufacture of medicinal products and pharmaceutical preparation containing them
12/21/2006	DE10104847B4 Tocopherol-Konzentrat und Verfahren zu seiner Herstellung Tocopherol concentrate and method for its preparation
12/21/2006	CA2611910A1 Anthranilic acid derivatives
12/21/2006	CA2610903A1 N-(pyridin-2-yl)-sulfonamide derivatives
12/21/2006	CA2610659A1 Reversible inhibitors of monoamine oxidase a and b
12/21/2006	CA2610428A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives
12/21/2006	CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative
12/20/2006	EP1734041A2 Platelet ADP receptor inhibitors
12/20/2006	EP1734037A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol"
12/20/2006	EP1733836A1 Processing method for organic crystal, processing device for organic crystal, and observing device for organic crystal
12/20/2006	EP1732919A1 Substituted thiophene derivatives as anti-cancer agents
12/20/2006	EP1732903A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
12/20/2006	EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
12/20/2006	EP1732895A2 Insecticidal n-substituted sulfoximines
12/20/2006	EP1732894A2 Process for preparing diimine compounds
12/20/2006	EP1732884A1 Sulphonamide derivatives
12/20/2006	EP1732865A1 Fluoridation method
12/20/2006	EP1732541A2 Cyclic compounds
12/20/2006	EP1670458B1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
12/20/2006	EP1565440B1 Novel process for the preparation of 2-aminomethylpyridine derivative
12/20/2006	EP1311483B1 Process for the preparation of 2-aminomethyl-halogen-pyridines
12/20/2006	EP1274688B1 Synthesis of intermediates useful in preparing tricyclic compounds
12/20/2006	EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006	CN1882545A Substituted nicotinoylcarbamates as pesticides
12/20/2006	CN1882544A Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease
12/20/2006	CN1882542A 2-pyridone derivatives as neutrophil elastase inhibitors and their use
12/20/2006	CN1882524A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/20/2006	CN1290825C Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds
12/20/2006	CN1290813C Process for the preparation of non-steroidal glucocorticoid receptor modulators
12/19/2006	US7151182 Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151112 TREATING A SUBJECT HAVING AN INFLAMMATORY DISORDER ALLEVIATED BY THE INHIBITION OF GRO- ALPHA CYTOKINES, or chemotaxis, with [5-(4-fluorophenylcarbamoyl)pyridin-2-yloxy]acetic acid butyl ester
12/19/2006	US7151106 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
12/19/2006	CA2203668C Method for preparing esters of halonicotinic acids
12/14/2006	WO2006133242A2 Azinone and diazinone v3 inhibitors for depression and stress disorders
12/14/2006	WO2006132837A1 l-HYDROXYCYCLOALKANECARBOXAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS
12/14/2006	WO2006132811A2 Ampa receptor potentiators
12/14/2006	WO2006132442A1 Vitamin d-like compound
12/14/2006	WO2006132296A1 Process for producing tricyclic ketone
12/14/2006	WO2006131711A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006	WO2005089269A3 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
12/14/2006	WO2005075425A3 Substituted bisarylurea derivatives as kinase inhibitors
12/14/2006	US20060281949 Method for production $g(a),$g(b)-unsaturated amide compounds
12/14/2006	US20060281926 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/14/2006	US20060281925 Method for producing coupling compound
12/14/2006	US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
12/14/2006	US20060281811 Synthesis of taxol enhancers
12/14/2006	US20060281767 Triazoloypyrimidines
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060280746 (1E)-1-{[(3-amino-4-methoxyphenyl)methyl]sulfinyl}-2-(2,4,6-trimethoxyphenyl)ethene; antiproliferative agents; offers protection from the cytotoxic effects of ionizing radiation and of cytotoxic chemotherapeutic agents
12/14/2006	DE102005025315A1 Ionische Flüssigkeiten mit niedriger Viskosität Ionic liquids with low viscosity
12/14/2006	CA2611609A1 Ampa receptor potentiators
12/14/2006	CA2610400A1 Azinone and diazinone v3 inhibitors for depression and stress disorders
12/14/2006	CA2610059A1 1-hydroxycycloalkanecarboxamide derivatives as bradykinin antagonists
12/14/2006	CA2609969A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1731148A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
12/13/2006	EP1730203A1 Catalyst composition and use thereof
12/13/2006	EP1730111A2 Substituted bisarylurea derivatives as kinase inhibitors
12/13/2006	EP1730106A1 Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound
12/13/2006	EP1730103A1 Formamide derivatives useful as adrenoceptor
12/13/2006	EP1730100A1 Polyamine analogs that activate antizyme frameshifting
12/13/2006	EP1729771A1 Pyridyl derivatives and their use as mglu5 receptor antagonists
12/13/2006	EP1729756A2 Novel pharmaceutical compositions
12/13/2006	EP0738260B2 Pesticides
12/13/2006	CN1878757A The derivatives of pyridone and use thereof
12/13/2006	CN1878554A 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/13/2006	CN1878466A Biphenyl derivative or salt thereof, pest control agent containing the same as active ingredient
12/13/2006	CN1876664A Organometallic complex and organic electroluminescent device using the same
12/13/2006	CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
12/13/2006	CN1876632A Solid phase time identification fluorescent immunity analysis chelant and its preparation method
12/13/2006	CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
12/13/2006	CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289467C Dibenzylamine compound and medicinal use thereof
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same
12/12/2006	US7148383 Can be used to prepare elements and devices suitable for use in optical communications
12/12/2006	US7148358 Process for the preparation of S(−) amlodipine-L(+)-hemi taratarte
12/12/2006	US7148357 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 633